Saturday, March 6, 2021

Latest:

Common myths and truths about lymphedema
Pandemic, power outages, and…policy on child poverty?
Proteomics analysis identifies potential drug targets for aggressive human cancers
Resonance podcast: Clinical education and the art of ballroom dancing
Image of the Month: The laboratory worm, C. elegans

Baylor College of Medicine Blog Network

Blog Network
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

lysosome

From The Labs

USP15 could be a target in ovarian cancer scientists have been looking for

May 8, 2018May 8, 2018 Ana Rodríguez 1 Comment lysosome, ovarian cancer, ovarian steroids, p53, p53-R175H, proteasome, Research, steroid receptor coactivator, USP 15

Ovarian cancer is currently treated with surgery and chemotherapy. Chemotherapy for ovarian cancer is based on drugs that act on any cell that is rapidly

From the Labs features an image of the laboratory worm, Caenorhabditis elegans. Image credit: Dr. Tao Chen/Wang lab.